Incidence and Risk of Treatment-Related Mortality with mTOR Inhibitors Everolimus and Temsirolimus in Cancer Patients: A Meta-Analysis

Open Access

Peer-reviewed

Research Article

Wei-Xiang Qi,

Affiliation Department of Oncology, the Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
⨯
Yu-Jing Huang,

Affiliation Department of Oncology, the Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
⨯
Yang Yao,

Affiliation Department of Oncology, the Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
⨯
Zan Shen,

Affiliation Department of Oncology, the Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
⨯
Da-Liu Min

* E-mail: yaoyang_6@163.com

Affiliation Department of Oncology, the Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai, China
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Cancer epidemiology
Is the Subject Area "Cancer epidemiology" applicable to this article?

Thanks for your feedback.